Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize NCX 470 in the Chinese market

December 17, 2018

View Press Release Corporate presentation Contact us
Previous